𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Replacement of conventional doxorubicin by pegylated liposomal doxorubicin is a safe and effective alternative in the treatment of non-Hodgkin's lymphoma patients with cardiac risk factors

✍ Scribed by Christian Johannes Schmitt; Sascha Dietrich; Antony Dick Ho; Mathias Witzens-Harig


Publisher
Springer
Year
2011
Tongue
English
Weight
172 KB
Volume
91
Category
Article
ISSN
0939-5555

No coin nor oath required. For personal study only.